Eyenovia, Inc. financial data

Symbol
EYEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
295 Madison Avenue,, Suite 2400, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 93.9 % -81.6%
Quick Ratio 16.7 %
Debt-to-equity 695 % +533%
Return On Equity -1.24K % -626%
Return On Assets -156 % -91.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 86.4M shares +95.9%
Common Stock, Shares, Outstanding 86.4M shares +101%
Entity Public Float 88M USD +65.7%
Common Stock, Value, Issued 8.64K USD +101%
Weighted Average Number of Shares Outstanding, Basic 69.6M shares +73.3%
Weighted Average Number of Shares Outstanding, Diluted 69.6M shares +73.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.63K USD +35.6%
Cost of Revenue 133K USD +888%
Research and Development Expense 16.6M USD +49.1%
General and Administrative Expense 13.9M USD +10.5%
Operating Income (Loss) -36.8M USD -57.7%
Nonoperating Income (Expense) -1.08M USD +32.1%
Net Income (Loss) Attributable to Parent -37.8M USD -48.8%
Earnings Per Share, Basic -0.72 USD/shares -10.8%
Earnings Per Share, Diluted -0.72 USD/shares -10.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.19M USD -65.3%
Inventory, Net 2.97M USD +5800%
Assets, Current 11.7M USD -55.9%
Property, Plant and Equipment, Net 2.75M USD -22.1%
Operating Lease, Right-of-Use Asset 1.28M USD -28.8%
Intangible Assets, Net (Excluding Goodwill) 6.12M USD +188%
Assets 22.8M USD -34.6%
Accounts Payable, Current 1.57M USD +10.4%
Employee-related Liabilities, Current 1.66M USD +20.4%
Liabilities, Current 15.8M USD +141%
Operating Lease, Liability, Noncurrent 836K USD -42%
Liabilities 19.1M USD -0.05%
Retained Earnings (Accumulated Deficit) -175M USD -27.5%
Stockholders' Equity Attributable to Parent 3.72M USD -76.4%
Liabilities and Equity 22.8M USD -34.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.89M USD -42.1%
Net Cash Provided by (Used in) Financing Activities 3.13M USD -7.84%
Net Cash Provided by (Used in) Investing Activities -114K USD +86.4%
Common Stock, Shares Authorized 300M shares +233%
Common Stock, Shares, Issued 86.4M shares +101%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.87M USD -56.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.19M USD -65.3%
Deferred Tax Assets, Valuation Allowance 30.4M USD +17.5%
Deferred Tax Assets, Gross 31.1M USD +18%
Operating Lease, Liability 1.44M USD -23.6%
Payments to Acquire Property, Plant, and Equipment 114K USD -87.6%
Lessee, Operating Lease, Liability, to be Paid 1.63M USD -27.4%
Property, Plant and Equipment, Gross 4.79M USD +148%
Operating Lease, Liability, Current 605K USD +36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 675K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 183K USD -72.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 193K USD -47%
Lessee, Operating Lease, Liability, to be Paid, Year Three 561K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 23.8M USD +18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 6M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 215K USD 0%
Operating Lease, Payments 74.1K USD -45.6%
Additional Paid in Capital 179M USD +16.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 248K USD +292%
Interest Expense 2.6M USD +53.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%